Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916

 

Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ


Open Access


Research (Published online: 03-02-2016)

2. Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats - K. Kavitha, A. Gopala Reddy, K. Kondal Reddy, C. S. V. Satish Kumar, G. Boobalan and K. Jayakanth

Veterinary World, 9(2): 118-122

 

 

   doi: 10.14202/vetworld.2016.118-122

 

 

K. Kavitha: Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, Hyderabad - 500 030, Telangana, India; kavithakalyan_23@yahoo.co.in

A. Gopala Reddy: Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, Hyderabad - 500 030, Telangana, India; gopalareddy123@rediffmail.com

K. Kondal Reddy: Department of Livestock Products Technology, College of Veterinary Science, Hyderabad - 500 030, Telangana, India; kkkredddy5@rediffmail.com

C. S. V. Satish Kumar: Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, Hyderabad - 500 030, Telangana, India; satish513512@gmail.com

G. Boobalan: Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, Hyderabad - 500 030, Telangana, India; bhupalvets@gmail.com

K. Jayakanth: Department of Veterinary Pharmacology and Toxicology, College of Veterinary Science, Hyderabad - 500 030, Telangana, India; dr.koppakajayakanth@gmail.com

 

Received: 15-07-2015, Revised: 10-12-2015, Accepted: 19-12-2015, Published online: 03-02-2016

 

Corresponding author: K. Kavitha, e-mail: kavithakalyan_23@yahoo.co.in


Citation: Kavitha K, Reddy AG, Reddy KK, Kumar CSVS, Boobalan G, Jayakanth K (2016) Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats, Veterinary World 9(2): 118-122.



Aim: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats.

Materials and Methods: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Sprague-Dawley rats. The rats were divided randomly into six groups of six rats in each. Group 1 was maintained as a normal control. Group 2 was maintained as diabetic control; Group 3 was treated with insulin; Group 4 with insulin + synbiotic; Group 5 with insulin + pioglitazone; and Group 6 with insulin + synbiotic + pioglitazone. All the animals were treated for 60 days.

Results: Body weights, and concentration of reduced glutathione (GSH), and high-density lipoproteins cholesterol were significantly (p<0.05) reduced, whereas the concentration of blood glucose, total cholesterol, triglycerides, protein carbonyls and thiobarbituric acid reacting substances, and the activity of GSH peroxidase were significantly (p<0.05) elevated in Group 2 at the end of 8th week as compared to Group 1. The treatment Groups 3, 4, 5 and 6 revealed improvement in all the parameters, and the highest improvement was observed in combination Group 6.

Conclusion: From this study, it is concluded that combination of insulin, pioglitazone and synbiotic is useful in treating diabetes.

Keywords: diabetes, insulin, oxidative stress, pioglitazone, synbiotic.



1. Wang, C., Guan, Y. and Yang, J. (2010) Cytokines in the progression of pancreatic β-cell dysfunction. Int. J. Endocrinol., 2010: 1-10.
http://dx.doi.org/10.1155/2010/515136
PMid:21113299 PMCid:PMC2989452
 
2. Shanmugam, K.R., Mallikarjuna, K. and Reddy, K.S. (2011) Effect of alcohol on blood glucose and antioxidant enzymes in the liver and kidney of diabetic rats. Indian J. Pharmacol., 43: 330-335.
http://dx.doi.org/10.4103/0253-7613.81504
PMid:21713042 PMCid:PMC3113389
 
3. Biswas, A., Rabbani, S.I. and Devi, K. (2012) Influence of experimental heart failure and hyperlipidemia in rats. Indian J. Pharmacol., 44: 333-339.
http://dx.doi.org/10.4103/0253-7613.96305
PMid:22701242 PMCid:PMC3371455
 
4. Pérez-Cobas, A.E., Moya, A., Gosalbes, M.J. and Latorre, A. (2015) Colonization resistance of the gut microbiota against Clostridium difficile. Antibiotics, 4: 337-357.
http://dx.doi.org/10.3390/antibiotics4030337
 
5. Canis, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A. and Lambert, D.M. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut, 58: 1091-1103.
http://dx.doi.org/10.1136/gut.2008.165886
PMid:19240062 PMCid:PMC2702831
 
6. Asemi, Z., Khorrami-Rad, A., Alizadeh, S.A., Shakeri, H. and Esmaillzadeh, A. (2014) Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial. Clin. Nutr., 33(2): 198-203.
http://dx.doi.org/10.1016/j.clnu.2013.05.015
PMid:23786900
 
7. Patterson, J.W. and Lazarow, A. (1955) Determination of glutathione. Methods Biochem. Anal., 2: 259-278.
http://dx.doi.org/10.1002/9780470110188.ch9
PMid:14393570
 
8. Paglia, D.E. and Valentine, W.N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70: 158-159.
PMid:6066618
 
9. Balasubramanian, K.A., Manohar, M. and Mathan, V.I. (1988) An unidentified inhibitor of lipid peroxidation in intestinal mucosa. Biochem. Biophys., 962: 51-58.
http://dx.doi.org/10.1016/0005-2760(88)90094-x
 
10. Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.G., Ahn, B.W., Shaltiel, S. and Stadtman, E.R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol., 186: 464-478.
http://dx.doi.org/10.1016/0076-6879(90)86141-H
 
11. Suthagar, E.S., Soudamani, S., Yuvaraj, S., Aruldhas, M.M. and Balasubramanian, K. (2009) Effects of streptozotocin-induced diabetes and insulin replacement on rat ventral prostate. Biomed. Pharmacother., 63: 43-50.
http://dx.doi.org/10.1016/j.biopha.2008.01.002
PMid:18313883
 
12. Derosa, G. and Maffioli, P. (2012) Peroxisome proliferator activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk. Curr. Mol. Pharmacol., 5: 272-281.
http://dx.doi.org/10.2174/1874467211205020272
PMid:22122457
 
13. Bogacka, I., Xie, H., Bray, G.A., and Smith, S.R. (2004) The effect of pioglitazone on peroxisome proliferator-activated receptor-γ target genes related to lipid storage in vivo. Diabetes Care, 27: 1660-1667.
http://dx.doi.org/10.2337/diacare.27.7.1660
PMid:15220243
 
14. Roselino, M.N., Pauly-Silveira, N.D., Cavallini, D.C., Celiberto, L.S., Pinto, R.A., Vendramini, R.C. and Rossi, E.A. (2012) A potential synbiotic product improves the lipid profile of diabetic rats. Lipids Health Dis., 11: 114.
http://dx.doi.org/10.1186/1476-511X-11-114
PMid:22963080 PMCid:PMC3502481
 
15. Devesh, C., Kritika, M., Anroop, N., Kumar, S.P. and Sumeet, G. (2012) Spirulina reverses histomorphological changes in diabetic osteoporosis in pioglitazone treated rats. J. Diabetes Metab., S1-006: 2-7.
http://dx.doi.org/10.4172/2155-6156.s1-006
 
16. Ozasa, H., Ayaori, M., Iizuka, M., Terao, Y., UtoKondo, H., Yakushiji, E. and Ikewaki, K. (2011) Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings from in vitro and ex vivo studies. Atherosclerosis, 219: 141-150.
http://dx.doi.org/10.1016/j.atherosclerosis.2011.07.113
PMid:21862012
 
17. Vitali, B., Ndagijimana, M., Maccaferri, S., Biagi, E., Guerzoni, M.E. and Brigidi, P. (2012) An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe, 18: 386-391.
http://dx.doi.org/10.1016/j.anaerobe.2012.04.014
PMid:22579985
 
18. Liong, M.T., Dunshea, F.R. and Shah, N.P. (2007) Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. Br. J. Nutr., 98: 736-744.
http://dx.doi.org/10.1017/S0007114507747803
PMid:17490507
 
19. Hsiao, P.J., Hsieh, T.J., Kuo, K.K., Hung, W.W., Tsai, K.B., Yang, C.H. and Shin, S.J. (2008) Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet. BMC Mol. Biol., 9(1): 82.
http://dx.doi.org/10.1186/1471-2199-9-82
 
20. D'Souza, A., Fordjour, L., Ahmad, A., Cai, C., Kumar, D. and Valencia, G. (2010) Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr. Res., 67: 526-531.
http://dx.doi.org/10.1203/PDR.0b013e3181d4ff2b
PMid:20101198
 
21. Mandal, A., Patra, A., Mandal, S., Roy, S., Mahapatra, S.D., Mahapatra, T.D., Paul, T., Das, K., Mondal, K.C. and Nandi, D.K. (2015) Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats. Clin. Exp. Nephrol., 19(2): 168-177.
http://dx.doi.org/10.1007/s10157-014-0971-4
PMid:24740592